Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection
• Carbapenem-resistant Enterobacteriaceae Infection
• Healthcare-associated Infection
• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: National University of Singapore | Conditions: Blood Stream Infections, Ventilator Associated Pneumonia | Phase 4 | Status: RECRUITING